NCT06918743

To Evaluate the Efficacy and Safety of RSS0393 Ointment in Patients With Plaque Psoriasis Phase II Study

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study Evaluating the Efficacy and Safety of RSS0393 Ointment Local Administration in Adults With Chronic Plaque Psoriasis

• Status: Not Yet Recruiting
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 147 (estimated)
• Sponsor: Jiangsu HengRui Medicine Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

To evaluate the efficacy and safety of RSS0393 ointment in patients with plaque psoriasis Phase II study

Conditions

• Psoriatic Subjects

Interventions

Type	Name	Description
DRUG	RSS0393 ointment	RSS0393 ointment 0.01%
DRUG	RSS0393 ointment	RSS0393 ointment 0.03%
DRUG	RSS0393 ointment placebo	RSS0393 ointment placebo

Timeline

• Start date: 2025-04-01
• Primary completion: 2026-03-01
• Completion: 2026-03-01
• First posted: 2025-04-09
• Last updated: 2025-04-09